COVID-19 vaccine trials conducted at Washington University, Saint Louis University
On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…
On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…
On Jul. 20, 2020, AstraZeneca announced that Interim results from the ongoing Phase I/II COV001 trial, led by…
On Jul. 16, 2020, Heron Therapeutics announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study…
On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
On Jul. 6, 2020, Regeneron announced the initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron’s investigational double antibody…
On Jul. 6, 2020, Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir…
On Jul. 2, 2020, French biotech company Abivax announced it had has treated the first patient in a…
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
On Jun. 23, 2020, the U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of…
On Jun. 23, 2020, FibroGen announced it has started enrollment for a Phase II clinical trial of pamrevlumab…
On Jun. 23, 2020, Mateon Therapeutics, a leading developer of TGF-β therapeutics, announced it has selected IQVIA to…
On Jun. 22, 2020, Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline…
On Jun. 19, 2020, GSK announced that a scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19…
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
On Jun. 13, 2020, AstraZeneca announced it had reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded…
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Company’s…
On Jun. 10, 2020, Johnson & Johnson announced that through its Janssen Pharmaceutical subsidiary it has accelerated the…
On Jun. 9, 2020, Immunic announced receipt of regulatory allowance from the FDA to initiate its phase 2,…
On Jun. 5, 2020, results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK)…
On Jun. 2, 2020, Pfizer announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will…
On Jun. 1, 2020, LabCorp announced that Covance, its drug development business, had created COVID-19 Clinical Trial Connect…
On Jun. 1, 2020, OPKO Health announced the U.S. Food and Drug Administration (FDA) had authorized OPKO to…
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetalone’s…
On Jun. 1, 2020, Proteostasis Therapeutics announced results from in vitro studies evaluating the use of PTI-129 as…
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
On May 19, 2020, Innovation Pharma announced that its anti-SARS-CoV-2 (COVID-19) drug candidate, Brilacidin, in an in vitro…